Direct sequencing of the human microbiome readily reveals community differences by Kuczynski, Justin et al.
In the past few years, the availability of improved sequen­
cing  methods,  including  pyrosequencing  [1],  has  revo­
lution  ized what we know about the microbes that inhabit 
our bodies. Although it has been known for decades that 
our  microbial  symbionts  outnumber  our  own  cells  by 
about a factor of 10 [2], the differences in the repertoires 
of symbionts harbored by different healthy individuals, 
different sites within the individual, and by individuals 
over time are only now coming to light. Initially, it was 
assumed that a ‘core microbiome’ existed; that is, that a 
substantial  number  of  microbial  species  was  shared  in 
each body habitat in all or most humans, and that the 
genomes of these core species could be used as scaffolds 
to assemble fragmentary data from short­read shotgun 
sequencing of microbial community DNA [3].
The first three individuals whose gut microbiomes were 
surveyed using substantial numbers of 16S rRNA gene 
sequences  shared  few  of  their  species,  however  [4]. 
Similarly, observations that a person’s left and right hands 
have only 17% of bacterial species in common, and that 
two  different  people’s  hands  share  only  13%  [5],  cast 
doubt on the concept of a substantial core set of microbial 
species shared by all or most people. This doubt has been 
reinforced by recent work that redefines core lineages or 
genes  as  ‘core’  even  if  shared  by  relatively  few  people 
[6,7]. In fact, on the basis of 16S rRNA gene analyses we 
can rule out the possibility that, even within relatively 
homogeneous  small  populations  of  fewer  than  100 
individuals, everyone’s skin­surface communities or gut 
communities share more than a tiny fraction of species 
[6­8]. This unanticipated variability in shared community 
membership, and also in other important aspects of the 
human  microbiome,  poses  substantial  conceptual  and 
compu  tational challenges.
Of particular importance for microbiome studies is the 
following question: what is the effect size? That is, using 
standard terminology from statistics, how distinguishable 
are two communities or groups of communities? Obtain­
ing an answer is essential for addressing many practical 
concerns  with  experimental  design.  For  example,  the 
effect size determines how many individuals need to be 
recruited  for  a  given  study,  and  how  many  sequences 
need to be collected per sample to observe differences if 
they exist. These considerations are particularly impor­
tant for the study of systemic disorders such as diabetes 
or some autoimmune disorders, which are expected to 
influence the microbiome in multiple body habitats. We 
need  a  sense  of  how  much  variation  exists  among 
different body habitats, how much variation is observed 
among healthy individuals for the same body habitat, and 
how much of a shift occurs due to a pathophysiologic 
state. It is also important to define the most appropriate 
method for determining the magnitude of similarity or 
difference between communities, as the choice of method 
has a large influence on the results of community com­
parisons [9­12]. A general discussion of the pros and cons 
of different metrics of community overlap is beyond the 
scope  of  this  paper  (see  [9­12]  for  reviews).  Here,  we 
summarize the types and sizes of effects found in studies 
that  used  various  methods  of  comparing  groups  of 
samples, and look for large­scale patterns that can give 
information on the number of individuals and sequences 
that  are  needed  to  observe  different  types  of  effects 
(Figure 1).
A variety of interrelated features differentiate microbial 
communities.  These  features  include  the  the  relative 
abundance of specific taxa (the proportion of the bacteria 
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of species richness or diversity observed within a com­
mu  nity (alpha diversity), and the degree to which differ­
ent  communities  share  membership  or  structure  (beta 
diversity). A major challenge in comparing studies is that 
there is no consistent way in which the size of community 
differences is reported, as the type of difference that is 
relevant  depends  on  the  study.  For  example,  lean  and 
obese mice and humans differ in their ratios of prominent 
bacterial phyla (Bacteroidetes (which include the common 
gut commensal Bacteroides), Firmicutes (Gram­positive 
bacteria, including Lactobacillus and Clostri  dium), and 
Actinobacteria  (which  include  Corynebacteria  and 
Mycobacteria) [13­15]); men’s and women’s hands differ 
in  the  number  of  species­level  phylotypes  (defined  as 
organisms with 16S sequence identity >97%) observed on 
average [5]; and samples from the same or similar sites on 
the bodies of different individuals cluster together using 
UniFrac­based  principal  coordinates  analysis  [4,16,17]. 
UniFrac is a metric for comparing microbial communities 
using phylogenetic information, which has been imple­
mented in several tools.
Because  of  the  diverse  ways  in  which  microbial 
communities respond to various environmental factors, 
it  is  difficult  to  compare  effect  sizes  across  different 
studies or systems, as an analysis that highlights differ­
ences in one system may obscure them in another. Thus, 
in  what  follows,  we  review  effect  types  and  sizes  as 
reported by the authors of individual studies. We focus 
on variation in human­associated microbial community 
Figure 1. The problem of distinguishing between sequences. (a) An investigator contemplating the problem of distinguishing between 
sequences from the gut of Equus asinus and the volar forearm of humans. (b) Our solution; guess the effect size based on the effect sizes reported 
in published studies; perform simulations based on these effect sizes as shown in Figure 2, and then acquire sufficient sequences to resolve 
microbial community differences of the expected magnitude. (c) When comparing the Equus asinus gut (white point) to human forearms (red and 
green points represent left and right arms, respectively), 100 or even 10 sequences per sample provide sufficient resolution, but one sequence per 
sample does not.provide sufficient resolution, but one sequence per sample does not.
(a)
(c)
(b)
100 10 1
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of  abundant  lineages,  using  various  measures  of  both 
within­  and  between­sample  diversity  (alpha  and  beta 
diversity,  respectively).  We  review  comparisons  of 
microbial communities in relationship to both sampling 
depth  (that  is,  number  of  sequences  per  sample)  and 
breadth (that is, number of samples or individuals). We 
then  perform  simulations  using  an  atlas  of  microbes 
associated with different sites in the human body to ask 
how many sequences per sample are needed in order to 
detect differences across individuals, time, and locations 
within the body.
Reported effect sizes between and within different 
body habitats
Table 1a provides an illustrative (though not exhaustive) 
overview of the literature regarding differences observed 
in  different  body  habitats  and  locations  in  healthy 
individuals, and the number of subjects and sequences 
that  were  used  to  identify  these  differences.  Although 
metagenomic studies that examine all the genes in the 
genome  are  also  of  immense  interest,  shotgun  meta­
genomic data are so far available only from the gut and 
for a relatively few samples, and so the range of questions 
that  can  be  addressed  at  present  is  substantially  more 
limited  than  for  16S  rRNA­based  surveys,  the  type  of 
survey we consider here. One robust finding that exem­
plifies relative effect sizes is that there appears to be a 
greater  degree  of  variation  in  microbial  community 
compo  sition between individuals than within the same 
individual over time (Table 1a). This has been found to be 
true in multiple studies and over a wide range of body 
habitats.  For  example,  gut  community  composition  is 
relatively stable in the same individual across a period of 
months  when  diet  is  consistent  [6,16],  and  even  to  a 
certain  degree  when  diet  is  altered.  (Changes  in  the 
Firmicutes:Bacteroidetes  ratio  have  been  reported  in 
individuals who lost weight, whether they were con  sum­
ing low­calorie fat­ or carbohydrate­restricted diets, but 
despite these shifts in relative abundance, interpersonal 
variation  was  the  largest  effect  observed  using  phylo­
genetic comparisons of the communities [14].) Likewise, 
skin  community  composition  is  more  similar  within  a 
subject than between subjects over a period of months 
[16,18],  as  are  oral,  nasal  and  external  auditory  canal 
communities  [16].  These  results  indicate  that  you  are 
likely to be more similar to yourself in 3 months time than 
to your friend today in terms of the bacteria you harbor.
Microbial community changes in human disease 
and environmental samples
Although a wide range of studies in healthy subjects have 
identified  substantial  interpersonal  variation  in  overall 
microbial community composition, how do these effect 
sizes compare with differences correlated with disease, or 
in  response  to  treatments  of  various  environmental 
samples? To address this question, we reviewed culture­
independent, 16S rRNA gene­based surveys associated 
with  different  physiological  conditions  (Table  1b)  and 
associated  with  experimental  manipulations  in  non­
human  environments  (which  were  surprisingly  scarce; 
Table 1c).
One of the best­characterized effects of health status 
on the gut microbiome is the association between obesity 
and  the  proportional  representation  of  Bacteroidetes, 
Firmicutes and Actinobacteria [6,13­15]. Studies in mice 
indicate  that  the  microbiota  contributes  to  the  obese 
state  by  providing  the  host  with  a  greater  amount  of 
energy from the diet compared with the microbiota of a 
lean host [15], as well as by manipulating host genes that 
regulate the deposition of energy in adipocytes [19]. The 
obesity­associated  microbiomes  of  humans  (and  mice) 
are  enriched  in  functional  genes  for  certain  types  of 
carbohydrate metabolism, and this is directly attributable 
to the reduction in the numbers of genomes of members 
of the Bacteroidetes [6,15].
However,  even  the  size  of  the  differences  in  gut 
bacterial  community  composition  of  obese  versus  lean 
hosts  is  debated,  as  different  studies  using  different 
methodologies  have  returned  varied  results  [20].  The 
impact of methodology is particularly evident in a study 
of twins concordant for obesity or leanness, in which the 
observed relative abundances of Bacteroidetes, Actino­
bacteria  and  Firmicutes,  as  judged  by  sequencing  of 
differ  ent regions of 16S rRNA clones, depended on the 
sequencing approach ­ pyrosequencing of PCR products, 
Sanger  sequencing  of  16S  rRNA  clones,  or  shotgun 
sequencing and phylogenetic classification of reads [6]. 
However, the direction of the effect was consistent across 
methodologies, and detectable with as few as a couple of 
hundred sequences per sample.
Observable phenotypes such as obesity may be caused 
by  a  variety  of  underlying  factors,  and  which  of  those 
factors is responsible for shifts in the host’s microbiota is 
difficult  to  address  in  such  correlative  studies.  Experi­
mental manipulations of microbial communities, however, 
allow  determination  of  the  relative  effects  of  specific 
variables on overall community composition or the abun­
dance of particular taxa, and as such, allow researchers to 
draw conclusions regarding cause and effect. Examples of 
experimental manipulations of non­human environments 
that used 16S rRNA gene sequencing approaches (either 
clone  libraries  or  pyrosequencing)  and  that  were  well 
enough replicated to allow statistical analysis are shown 
in Table 1c. For soil samples, three to four replicates with 
70 to 100 sequences were sufficient to observe differences 
in microbial communities due to land use and moisture 
regimes [21,22]. For piglet gut microbiota, the effects of 
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Page 3 of 9Table 1. Variations observed among different types of microbial communities, and the extent of sequencing and 
sampling used
      Total   
      number  Average 
    Number  of 16S  number of 
  Number  of  sequences sequences 
  of  samples  in final  per 
Topic  subjects  sequenced   analysis  sample  Study conclusions  Reference
(a) Microbial communities associated with healthy humans
Oral  120  120  14,115  118  Collected saliva from 10 individuals at each of 12 globally widespread   [38] 
(saliva)          locations. They attributed approximately 13.5% of the total variation in the  
          distribution of genera to differences between individuals and found little  
          evidence for geographic structure: 11.7% of the variation was among  
          individuals from the same location while just 1.8% was among individuals  
          from different locations
Oral   3  29  298,261  10,285  Collected samples from various oral niches of three individuals; 26% of the  [39] 
(tooth, tongue,           unique sequences and 47% of species-level phylotypes found in the study 
buccal mucosa,           were found in all three subjects. Bacterial community composition was 
palate)           shaped primarily by oral niche: principal components analysis differentiated  
          communities from shedding (tongue, cheek, palate) versus tooth surfaces
Skin   6  20  2,038  102  Sampled the superficial left and right volar forearms of six healthy subjects  [40]
(right and left           (four of whom were sampled again 8 to 10 months later). Samples from 
volar forearm)           the same subject at the same time point (left versus right) were not  
          significantly different, whereas samples from the same subject at different  
          time points could be significantly different
Skin   51  102  351,630  3,251  Collected skin swabs from the left and right palms of 51 volunteers. On  [5] 
(right and           average, individuals shared only 17% of species-level phylotypes between 
left palms)           their right and left palms, while only 13% of species-level phylotypes were  
          shared between different individuals. (UniFrac similarity between hands from  
          different individuals = 0.30, and the same individual = 0.36 to 0.38.) Palm  
          surface bacterial community structure was determined by handedness, time  
          since washing, and the individual’s sex
Skin   10  300  112,283  374  Obtained samples from 20 skin sites on each of 10 individuals (half of whom  [18] 
(20 skin sites,           were sampled twice). They found that interpersonal variation in community 
including moist,           membership and structure depended on skin site, and that subjects were 
dry, and           more similar to themselves (site-to-site) than to others. Four of the five 
sebaceous sites)           re-sampled subjects were also more similar to themselves over time than they  
          were to other volunteers. Bacterial community composition was shaped by  
          microhabitat: sebaceous, moist, or dry
Gut  3  18  11,831  657  Interpersonal and site-to-site variation in three subjects at six sites.   [4] 
          Between subject dissimilarity was greater than within subject dissimilarity
Gut  154  281  1,947,381  6,930  Interpersonal variation was found to be largest between unrelated individuals,   [6] 
          smaller between children and their mothers, still smaller between twins, and  
          dramatically smaller in the same individual over time. (Average UniFrac distance  
          over time within-individual = 0.69 and between unrelated individuals = 0.80)
(b) Microbial communities and human disease
Obesity  12 subjects  50  18,348   367  Obese people have fewer Bacteroidetes (5%; P < 0.001) and more Firmicutes   [14]
  2 controls        (85%; P = 0.002) than lean controls (25% Bacteroidetes and 75% Firmicutes). 
          During the diet, the relative abundance of Bacteroidetes increased from 5 to 20%  
          (P < 0.001) and the abundance of Firmicutes decreased from 85 to 75% (P = 0.002). 
          Increased abundance of Bacteroidetes correlated with percentage loss of body  
          weight (R2 = 0.8 for the CARB-R diet and 0.5 for the FAT-R diet, P < 0.05), and not 
          with changes in dietary calorie content over time (R2 = 0.06 for the CARB-R diet 
          and 0.09 for the FAT-R diet)
Diabetes  10 Diabetic patients   20  382,229   37,001  The proportion of Firmicutes was significantly higher (P = 0.03) in the controls   [41]
  10 healthy subjects*    357,782    (mean 56.4%) compared to the diabetic group (mean 36.8%). Accordingly, phyla  
          Bacteroidetes and Proteobacteria were somewhat but not significantly enriched  
          in the diabetic group (50.4 and 4.1% in the diabetic group compared with 35.1  
          and 2.7% in the healthy group, respectively)
Crohn’s   6 CD patients  16  1,590  207  Proteobacteria were significantly (P = 0.0007) increased in CD patients (13%)   [42]
disease   5 UC patients    678    versus UC patients (9.4%) or healthy subjects (8.5%). Bacteroidetes were far 
(CD) and   5 healthy subjects    1,037    less diverse than Firmicutes, containing only 32 phylotypes, versus 87 species- 
ulcerative           level phylotypes in the latter phylum, but were nevertheless the most abundant,  
colitis (UC)          representing over 70% of total clones. Bacteroidetes were significantly increased  
          (75%) in CD patients versus UC patients (64.3%) or healthy subjects (67.4%) The  
          increase in Bacteroidetes and Proteobacteria was accompanied by a significant  
          (P = 0.0001) decrease in Firmicutes (CD,10%; UC, 25.8%; healthy subjects, 24%), all 
          belonging to the class Clostridia in the CD group
Continued overleaf
Kuczynski et al. Genome Biology 2010, 11:210 
http://genomebiology.com/2010/11/5/210
Page 4 of 9Table 1. Continued
      Total   
      number  Average 
    Number  of 16S  number of 
  Number  of  sequences sequences 
  of  samples  in final  per 
Topic  subjects  sequenced   analysis  sample  Study conclusions  Reference
CD and   20 CD patients  49   809   35   The results obtained from CD and healthy subject samples did not differ   [43] 
UC  15 UC patients     691    (P > 0.05). Bacterial numbers associated with non-inflamed and inflamed
  14 healthy subjects     235    mucosa within CD and UC groups did not differ (P > 0.05). The ratio of 
          Actinobacteria:Bacteroidetes:Firmicutes: Proteobacteria differed between  
          healthy (approximately 1:27:53:6%), UC (approximately 0.3:34:48:7%) and CD  
          subjects (approximately 0.5:34:40.5:6%) 
CD and   190 CD, UC or  190   15,172   80   Bacteroidetes (10%, P = 0.001) and Firmicutes (20%, P = 0.001) were greatly  [44]
UC  healthy patients         depleted while Actinobacteria (10%, P = 0.001) and Proteobacteria (50%, 
  (around equal         P = 0.001) were substantially more abundant in the inflammatory bowel 
  numbers)         disease (IBD) subset samples, relative to control subset samples (approximately  
          20% Bacteroidetes, approximately 50% Firmicutes, approximately  
          5% Actinobacteria, approximately 10% Proteobacteria) 
Necrotizing   10 infants  21  5,354   255   For the control infants four phyla were present: Proteobacteria, (34.97% relative  [45] 
enterocolitis   with NEC and         abundance), Firmicutes (57.79%), Bacteroidetes (2.45%) and Fusobacteria (0.54%)  
(NEC)  10 healthy infants         with 4.25% unclassified bacteria. However, NEC patients had only two phyla,  
          Proteobacteria (90.72%) and Firmicutes (9.12%) with 0.16% unclassified bacteria.  
          The average proportion of Proteobacteria was significantly increased and the  
          average proportion of Firmicutes was significantly decreased compared to  
          controls (P = 0.001)
Clostridium   4 ICD patients  10  581  143  Using rarefaction curves, species richness in the patients with ICD (initial  [46]
difficile-  3 RCD patients    447    episode of antibiotic-associated diarrhea due to C. difficile) was similar to that
associated   3 healthy subjects    399    in the control subjects, with the shape of the curve revealing that the total 
diarrhea           richness of the microbial community had not been completely sampled 
(CDAD)           (minimum of 20 phylotypes). However, the species richness in the patients  
          with RCD (recurrent antibiotic associated diarrhea due to C. difficile ) was 
          consistently lower (around ten phylotypes) than both that in the patients with  
          ICD and that in the control subjects
Gastric   10 non-cardia  15   140   9   No significant differences in microbial compositions were found between   [47] 
cancer  gastric cancer patients         cancer patients and controls 
  5 control patients       
Helicobacter   19 H. pylori (+)   23  1,833   80  Subjects negative for H. pylori had twice as many Fusobacteria as H. pylori-  [48]
pylori   subjects        positive subjects (10% compared to 5%, respectively). Twenty percent of the
colonization  4 H. pylori (-)         clone libraries derived from H. pylori-positive patients were non-H. pylori
  subjects        Proteobacteria compared with 10% in the control subjects; this was also the  
          case for Bacteroidetes (20% compared with 10% in the control)
(c) Experimentally manipulated microbial communities
Restoration   3 agriculture  13  1,235  95  A significant difference in the Proteobacteria:Acidobacteria ratio from around  [22] 
of wetland   wetlands,         0.6 to around 0.4 was observed between agricultural and reference wetlands,  
soils  3 restored         respectively (P < 0.001). A difference was also found in the relative abundance
  wetlands and         of β-Proteobacteria from 14 to 3% in the same soils (P < 0.001)
  3 reference wetlands        
Soil   4 wet and  8  665  83  The relative abundance of Proteobacteria decreased from 48 to 36% in wet  [21] 
moisture   4 dry soils         versus dry plots (P < 0.05). Acidobacteria increased in relative abundance from 
          7 to 23% in the same soils (P < 0.01) 
Antibiotic   6 control pigs  12  1,900  171  An effect of antibiotics was seen on the overall community composition  [23] 
effects on   and 6 pigs        (P < 0.03)
piglet gut   treated with 
microbiota  chlor-tetracycline 
Effects of a   4 to 5 fasted  38  145,428  3,827  The fast resulted in a significant increase in the proportion of Bacteroidetes  [49]
24-hour fast   and control mice        (approximately 21 to approximately 42%, P = 0.01) and a significant decrease
on mouse gut           in the fraction of Firmicutes (approximately 77 to around 53%, P = 0.007) within
microbiota           the gut microbial community
Effects of diet   5 individuals  20  25,790  1,290  The relative abundance of Bacteroidetes decreased (around 90% versus  [50]
and   from 2 genotypes        around 40%) in animals fed the high-fat diet regardless of genotype (P < 0.001). 
genotype on   fed standard        Likewise, mice fed the standard chow diet showed a lower relative abundance of 
murine gut   or low-fat chow        Firmicutes (around 7 versus around 42) independent of genotype (P < 0.001)
microbiota 
Antibiotic   5 dogs  15  44,096  2,940  Enterococcus-like organisms, Pasteurella species, and Dietzia species all  [51] 
effects on   sampled        increased significantly (P < 0.05) following tylosin treatment
canine gut   three times 
microbiota 
*The entire study consisted of 36 subjects of which only 20 were selected for pyrosequencing.
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Costello et al. [16] found that variation in membership of bacterial communities was primarily explained by body habitat, secondarily 
by host individual (within habitats), and finally by time (within habitats and individuals). Specifically, variation in species composition 
measured using the unweighted UniFrac metric was 1.19 times larger between habitats than within habitats. Within habitats, interpersonal 
variation was 1.15 times larger than variation within individuals over time. Within habitats and individuals, variation over 3 months was 
1.06 times larger than variation over 24 hours. Thus, the smallest effect size observed showed that samples collected 24 hours apart were 
significantly more similar to each other than to those collected 3 months apart.
The influence of sequencing depth on the ability to recapture these differences can be conveniently tested by simulating the effects 
of sampling fewer sequences and then performing comparisons of bacterial community membership using the unweighted UniFrac 
metric [26]. The UniFrac metric measures the difference between two communities in terms of the amount of evolutionary history that 
is unique to either of the two: for a pair of communities, the sum of the lengths of the branches on a phylogenetic tree that leads only 
to members of one community divided by the sum of the lengths of the branches that lead to members of either community yields 
the UniFrac distance between the communities [26]. Using the QIIME (Quantitative Insights Into Microbial Ecology) software package, 
we randomly drew sequences from samples at various depths below the original study’s 1,315 ± 420 (standard deviation) sequences 
per sample, then calculated UniFrac distance between all pairs of samples. Using only ten sequences per sample, the main results of the 
original study were recovered: variation between samples was most prominent for samples from different body habitats; and for the same 
body habitat, samples originating from different individuals varied more than samples originating from the same indivdual over time. 
The original study [16] also found that among samples from the same body habitat on the same individual, samples varied more when 
separated by 3 months than when separated by only 24 hours; our reanalysis using only 10 sequences per sample only suggested this 
result (Figure 2a,b).
These same UniFrac distances can be used with the program PRIMER v6 [27] to assess the partitioning of the variability in distances in 
multivariate space using nested models and PERMANOVA [28], a technique that uses label permutations to estimate the distribution of 
their test statistics under the null hypothesis that within-group distances are not significantly different from between-group distances. 
In this analysis, PERMANOVA uses the UniFrac distances to compute a test statistic similar to an F-ratio, and then reports both the 
significance of the statistic and the portion of variation explained by each nested level of factor. Figure 2c shows the portion of variation 
explained in PERMANOVA in response to sequencing depth when run with the default settings using the nested experimental design 
Month(Person(Habitat)), featuring Habitat as the highest hierarchical level. Remarkably, this analysis shows that a relatively low sequencing 
depth is sufficient to allow us to partition variability in bacterial community membership among the various factors in our experimental 
design, and to rank correctly the relative importance of these factors. For example, the observation that bacterial community composition 
varied less over 24 hours than over 3 months became significant when 50 or more sequences per sample were obtained (PERMANOVA 
Monte Carlo P < 0.001). These results are consistent with previous work from several groups showing that broad-scale trends in microbial 
community analysis can be recaptured with samples consisting of only a few dozen sequences [29-32].
Related techniques can be used to address the potential of using a deeply sequenced reference dataset to classify sparsely sequenced 
microbial samples. This approach is likely to be increasingly relevant as sequence-based microbial ecology studies grow both in number 
and in extent, and as reference databases become more extensive and user friendly. In this analysis, each narrowly defined body site from 
Costello et al. [16] (for example, volar forearm, forehead, and so on) is compared with each other site. For each pair of sites, one sample 
was selected: how many sequences from that sample were required to identify which of the two body sites it came from? A given depth 
of sequencing (‘Seqs for 95% cluster accuracy’ in Figure 2d) was considered sufficient for discrimination when it placed the test sample 
closer to samples from the same body site than to samples from the other body sites under consideration more than 95% of the time. As 
expected, correct discrimination in this manner requires deeper sequencing when the differences between body sites are more subtle. 
For example, body sites within the broader skin habitat, such as palm and knee, often required well over 100 sequences for discrimination, 
whereas dissimilar habitats such as the oral cavity and hair rarely required more than 100 sequences for discrimination.
The effect sizes in this type of analysis can be quantified using an adaptation of the population-genetics statistic known as the ‘fixation 
index’, or FST. FST was originally used to detect genetically based population subdivision (also known as genetic differentiation) among 
populations of animals or plants within a species [33], but can easily be adapted to measure the degree of differentiation between clusters 
(or categories) of microbial communities [12]. Values of FST typically range from 0 to 1, where 0 indicates no differentiation and 1 indicates 
complete differentiation. Hudson et al. [34], following Slatkin [35], provide a simple definition of FST that is easily adapted to microbial 
community distance metrics such as Unifrac distances: FST = (PBetween - PWithin)/PBetween, where PBetween and PWithin represent the average Unifrac 
distances between and within samples, respectively, from two categories. The FST is reported as the abscissa in Figure 2d. For many pairs of 
body habitats, surprisingly few sequences (often fewer than ten) are required to classify a new habitat, although with smaller effect sizes 
more sequences are frequently required. It is important to note that, as with any assessment of beta diversity, these patterns are due to 
differences in the most abundant species in each sample; the effects of the rare biosphere [36] will inherently be lost as sampling depth 
decreases. However, the importance of rare species (that is, alpha diversity) in human body habitats generally has yet to be shown. If rare 
species do turn out to correlate better with physiological states than does overall community composition, deeper sequencing will be 
required. However, overall patterns can be recovered with surprisingly few reads, and a focus on the common species that make up most 
of the biomass has been useful in many other ecosystems as well.
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with as few as 96 sequences per sample [23]. It would be 
fascinating to test whether similar antibiotic­induced effects 
in outbred populations of humans with diverse diets [24] can 
be found with relatively few sequences. Similarly, it would be 
important  to  consider  sampling  depth  under  human 
physiological  conditions  in  cases  where  the  effect  size  is 
known to be large, for example, in the development of the 
infant gut microbiota [25].
Has the depth of sequencing used up to now really 
been necessary?
The  literature  reviewed  in  Table  1  reports  how  many 
sequences  were  used  to  reveal  a  variety  of  different 
Figure 2. Variation in human body habitats within and between people. (a) The full dataset (approximately 1,500 sequences per sample); 
(b) the dataset sampled at only 10 sequences per sample, showing the same pattern; (c) the relationship between sequencing depth and the 
PERMANOVA component of variation. The amount of variation explained by the factors plateaus at relatively shallow sequencing depths. Note 
that the proportion of variation captured by differences between the samples (that is, residual variation) is still highest despite the explanatory 
values of the three factors examined. (d) Effect size determines the number of sequences required for sample identification. Each point in the 
figure represents a specific sample selected from a pair of body sites, and the number of sequences required to correctly distinguish which site the 
sample originated from. The point is colored according to the two body sites under consideration, the center’s color represents the broad category 
the selected sample originated from, the border color represents the other broad category under consideration. Many body sites share the same 
broad category, and thus some points have the same border and center coloring. Red, external ear canal; yellow, hair; green, oral cavity; blue, gut; 
magenta, skin; gray, nostril. ns, not significant.
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Page 7 of 9effects. Could the same results have been achieved with 
less sequencing? To begin to address this question, we 
carried  out  a  limited  reanalysis  of  a  study  of  multiple 
body habitats by Costello et al. [16], which encompasses 
variability explained by nested factors with different effect 
sizes (Box 1).
In  conclusion,  the  results  described  here,  and  pre­
viously reported [8,37], show that arbitrarily choosing to 
generate  large  numbers  of  sequences  may  not  be  the 
most cost­effective way to identify changes in microbial 
communities  associated  with  different  physiological  or 
pathophysiological states. Instead, we call for a few stan­
dard  ized methods to assess differences among microbial 
communities, which will allow for effect size and power 
calculations,  and  therefore  a  considered  assessment  of 
the  number  of  individuals  and  sequences  required  to 
differentiate  among  given  communities.  The  following 
four methods have been successful in a range of studies: 
differences  in  alpha  diversity  (number  of  phylotypes 
observed  or  extrapolated);  differences  in  abundance  of 
specific  lineages;  differences  in  location  on  a  principal 
coordinates  plot  obtained  from  UniFrac  distances  or 
other  metrics;  and  the  FST  measure  described  in  the 
previous section.
The rapid increase in sequencing capacity provides a 
spectacular  opportunity  to  advance  the  field  in  ways 
that  were  unimaginable  even  3  years  ago.  How  can 
individual investigators, or groups of investigators, use 
these resources most wisely at this unique moment of 
democratization  of  the  ability  to  perform  sequence­
based studies? The data summarized here suggest that 
study designs consisting of tens of thousands of samples 
sequenced at shallow coverage will be highly informative 
(depending  on  the  effect  size),  and  such  studies  are 
possible  with  the  instruments  available  today.  Given 
recent  observations  that  inter­habitat  and  inter­
personal  variations  are  large  effects,  we  believe  that 
individual  researchers  can  and  should  sieze  the 
opportunity provided by these findings to analyze vast 
numbers of samples at low­coverage (for example, 100 
to 1,000 sequences). At this number of samples, detailed 
explora  tion  of  spatial  and  temporal  dynamics  of 
microbial  communities  will  be  possible,  as  will 
comparisons of large patient populations. In addition, 
replicate samples can be acquired and analyzed without 
too strongly impairing the breadth of an investigation, 
allowing  more  robust  experimental  designs  to  be 
implemented. One can envisage that perhaps within the 
next  few  years,  a  group  of  motivated  high­school 
students  might,  for  a  science­fair  project,  be  able  to 
track  movements  in  microbes  between  humans  and 
their pets and livestock across the planet. These studies, 
especially  when  combined  with  hypothesis­driven 
approches to understanding the effects of factors such 
as  diet  and  antibiotic  exposure,  could  go  far  beyond 
even  the  largest  purely  observational  studies  being 
contemplated today.
Such  studies  will  yield  an  overall  map  of  variation 
within  the  human  microbial  ecosystem,  and  relate 
differences  to  specific  physiological  states  within  and 
between individuals in a manner that is replicated across 
individuals. These studies will serve as a framework to 
identify  and  compare  the  shifts  that  take  place  in  the 
microbial community that are related to specific disorders.
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